Deming David H
Reporting owner on Forms 3, 4 and 5, CIK 1641063.
Deming David H reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PHIO · Phio Pharmaceuticals Corp.CIK 1533040 | director | 2 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PHIO · Phio Pharmaceuticals Corp.Common Stock, $.0001 par value | 2026-11-13 | P bought | +3,000 | $0.8334 | 61,800 | Form 4 |
| PHIO · Phio Pharmaceuticals Corp.Common Stock, $.0001 par value | 2026-11-12 | P bought | +9,000 | $0.8136 | 58,800 | Form 4 |
| PHIO · Phio Pharmaceuticals Corp.Common Stock, $.0001 par value | 2026-11-11 | P bought | +5,200 | $0.838 | 49,800 | Form 4 |
| PHIO · Phio Pharmaceuticals Corp.Common Stock, $.0001 par value | 2026-11-10 | P bought | +6,800 | $0.8395 | 44,600 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001683168-26-008786 | Phio Pharmaceuticals Corp. | 2026-11-16 | ||
| Form 4 0001683168-26-008544 | Phio Pharmaceuticals Corp. | 2026-11-12 |